Skip to main content
. 2022 Feb 28;37(1):159–169. doi: 10.3803/EnM.2021.1299

Table 2.

Thyroid Core Needle Biopsy Results and Histologically Confirmed Diagnosis

CNB category No. Histologic confirmation Benign NIFTP Malignant ROM without NIFTP, % ROM with NIFTP, %
I 39 9 (23.1) 4 0 5 13–56 13–56

II 841 28 (3.3) 25 1 2 0.2–7.1 0.4–10.7

III 17 4 (24) 3 0 1 6–25 6–25
 IIIa 3 0 0 0 0 NA NA
 IIIb 6 3 (50) 2 0 1 17–33 17–33
 IIIc 0 NA NA NA NA NA NA
 IIId 3 1 (33) 1 0 0 0 0
 IIIe 5 0 0 0 0 NA NA

IV 241 148 (61.4) 70 14 64 26.6–43.2 32.4–52.7
 IVa 144 91 (63.2) 51 7 33 22.9–36.3 27.8–44.0
 IVb 57 37 (65) 8 6 23 40–62 51–78
 IVc 39 19 (49) 11 1 7 18–37 21–42
 IVd 1 1 (100) 0 0 1 100 100

V 7 4 (57) 0 0 4 57–100 57–100

VI 236 236 (100) 0 0 236 100.0 100.0

Total 1,381 429 (31.1) 102 15 312 22.6–72.7 23.7–76.2

Values are expressed as number (%). The upper bound of the ROM was calculated by having all resected cases as denominator. The malignant cases (category VI) diagnosed by CNB were considered as histologically confirmed cases. The lower bound of ROM was calculated by having the total number of CNB cases as denominator.

CNB, core needle biopsy; NIFTP, noninvasive follicular thyroid neoplasm with papillary-like nuclear feature; ROM, risk of malignancy; NA, not available.